Dartisla ODT™ (glycopyrrolate) – New drug approval
On December 17, 2021, Edenbridge Pharmaceuticals announced the FDA approval of Dartisla ODT (glycopyrrolate) orally disintegrating tablets, in adults to reduce symptoms of a peptic ulcer as an adjunct to treatment of peptic ulcer.
Download PDF
